Go Pro

TriSalus Life Sciences (TLSIW) 10K Form and Latest SEC Filings 2026

TriSalus Life Sciences logo
$0.90 0.00 (0.00%)
Closing price 08/28/2026
Extended Trading
$0.92 +0.03 (+2.78%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest TriSalus Life Sciences SEC Filings & Recent Activity

TriSalus Life Sciences (NASDAQ:TLSIW) has submitted 340+ documents to the U.S. Securities and Exchange Commission (SEC) since 2020. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in TriSalus Life Sciences's financial statements. The most recent filing was a Form 10-Q submitted on August 6, 2026.

Form 4
TriSalus Life Sciences, Inc. Reports Ownership Change on Jul. 6, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
TriSalus Life Sciences Files Quarterly Report on Aug. 6, 2026

The 10-Q contains TriSalus Life Sciences's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

TriSalus Life Sciences SEC Filing History

Browse TriSalus Life Sciences' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/06/2026 3:04 PM
TriSalus Life Sciences (1826667) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/07/2026 3:39 PM
First Light Asset Management, LLC (1600004) Filed by
TriSalus Life Sciences (1826667) Subject
Form SCHEDULE 13G/A
07/06/2026 3:01 PM
Patience David (1970009) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 3:01 PM
Marshak Richard (1982638) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
07/01/2026 3:02 PM
Marshak Richard (1982638) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 3:03 PM
Szela Mary T (1410289) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
07/01/2026 3:04 PM
Szela Mary T (1410289) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 3:30 PM
Marshall Richard Henry (2142265) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 3
Initial statement of beneficial ownership of securities  
06/29/2026 3:33 PM
Marshall Richard Henry (2142265) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 3:42 PM
Gordon Gary B. (1811354) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 3:42 PM
Patience David (1970009) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 3:42 PM
Szela Mary T (1410289) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 3:42 PM
Stansky Michael P (1424204) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 3:42 PM
TriSalus Life Sciences (1826667) Issuer
Wahlstrom Mats (1459154) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 3:44 PM
First Light Asset Management, LLC (1600004) Filed by
TriSalus Life Sciences (1826667) Subject
Form SCHEDULE 13G
05/12/2026 3:03 PM
TriSalus Life Sciences (1826667) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2026 7:30 AM
TriSalus Life Sciences (1826667) Subject
Utmost Group Plc (2046077) Filed by
Form SCHEDULE 13G
04/29/2026 3:32 PM
TriSalus Life Sciences (1826667) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2026 3:36 PM
Frankenius Equity AB (1988262) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2026 8:10 AM
TriSalus Life Sciences (1826667) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2026 3:09 PM
MATLIN DAVID J (1251956) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2026 3:25 PM
Szela Mary T (1410289) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2026 3:25 PM
Stevens Jennifer (1982621) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2026 3:25 PM
Marshak Richard (1982638) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2026 3:25 PM
Cox Bryan F. (1981787) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2026 3:25 PM
Devlin Jodi (1992151) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 3:08 PM
TriSalus Life Sciences (1826667) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2026 3:31 PM
TriSalus Life Sciences (1826667) Filer
Form 424B5
02/23/2026 3:08 PM
Stansky Michael P (1424204) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:08 PM
Szela Mary T (1410289) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:08 PM
TriSalus Life Sciences (1826667) Issuer
Valle William (2018493) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:08 PM
Gordon Gary B. (1811354) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:08 PM
Patience David (1970009) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2026 3:15 PM
TriSalus Life Sciences (1826667) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2026 5:50 PM
Stansky Michael P (1424204) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 3
Initial statement of beneficial ownership of securities  
02/11/2026 5:51 PM
Stansky Michael P (1424204) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2026 7:59 AM
TriSalus Life Sciences (1826667) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2026 6:09 AM
TriSalus Life Sciences (1826667) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2025 11:15 PM
TriSalus Life Sciences (1826667) Filer
Form EFFECT
11/25/2025 3:15 PM
Cox Bryan F. (1981787) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2025 2:40 PM
Patience David (1970009) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
11/25/2025 2:42 PM
Marshak Richard (1982638) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2025 2:43 PM
Stevens Jennifer (1982621) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2025 2:55 PM
Szela Mary T (1410289) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2025 2:56 PM
Devlin Jodi (1992151) Reporting
TriSalus Life Sciences (1826667) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 3:40 PM
TriSalus Life Sciences (1826667) Filer
Form S-3
Registration statement under Securities Act of 1933  
11/03/2025 9:00 AM
TriSalus Life Sciences (1826667) Subject
Utmost Group Plc (2046077) Filed by
Form SCHEDULE 13G
10/01/2025 3:28 PM
TriSalus Life Sciences (1826667) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

TriSalus Life Sciences SEC Filings - Frequently Asked Questions

TriSalus Life Sciences (TLSIW) has submitted 340+ filings to the SEC since 2020. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 10-Q submitted on August 6, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:TLSIW are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/6/2026. New filings are added as they're published.
From Our Partners